Zhong Qiao, Lin Chia-Yu, Clarke Kristen J, Kemppainen Robert J, Schwartz Dean D, Judd Robert L
Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, 219 Greene Hall, Auburn, AL 36849-5518, USA.
Biochem Biophys Res Commun. 2002 Aug 16;296(2):383-7. doi: 10.1016/s0006-291x(02)00882-3.
Resistin is an adipocyte-derived hormone whose role in the development of insulin resistance is controversial. Endothelin-1 (ET-1) is a 21 amino acid peptide demonstrated to possess vasoconstrictor, positive inotropic, mitogenic, and metabolic properties. In numerous disease states, including congestive heart failure, obesity, and diabetes, elevated levels of ET-1 have been reported and are thought to contribute to the pathology of the disease. A recent study demonstrated that ET-1 induces the expression and stimulates the secretion of the adipose tissue-derived hormone leptin. However, the effect of ET-1 on resistin secretion has not been determined. To characterize the effect of ET-1 on resistin secretion, 3T3-L1 fibroblasts were differentiated into adipocytes and allowed to mature for 14 days. Cells were incubated for 24h with ET-1 (1-100 nM), insulin (1-100 nM), insulin+ET-1 (100 nM I+E) or the appropriate vehicle or antagonist. At the end of the incubation period, resistin secretion was determined in the media by immunoblotting and densitometric analysis. ET-1 (1-100 nM) significantly decreased basal resistin secretion by 49% (1 nM), 43% (10nM), and 59% (100 nM). Insulin (1-100 nM) produced a concentration-dependent increase in resistin secretion from 3T3-L1 adipocytes (1 nM-42%, 10nM-55%, and 100 nM-86% vs. control). Insulin-stimulated resistin secretion (100 nM) was almost completely inhibited (94%) by ET-1 (100 nM). The effects of ET-1 on resistin protein secretion were inhibited by co-incubation with the ET(A) receptor antagonist BQ-610. In conclusion, our studies demonstrate that basal and hormonal stimulation of resistin secretion by insulin are inhibited by ET-1. Such findings demonstrate that resistin secretion is regulated in a similar manner to other adipose tissue factors, including leptin, in 3T3-L1 adipocytes. In addition, our findings suggest that vascular factors such as ET-1 may regulate whole body energy metabolism through adipocyte-derived hormones, including leptin and resistin.
抵抗素是一种由脂肪细胞分泌的激素,其在胰岛素抵抗发生发展中的作用存在争议。内皮素 -1(ET -1)是一种含有21个氨基酸的肽,具有血管收缩、正性肌力、促有丝分裂和代谢特性。在许多疾病状态下,包括充血性心力衰竭、肥胖症和糖尿病,都有报道称ET -1水平升高,并且认为其与疾病的病理过程有关。最近一项研究表明,ET -1可诱导脂肪组织衍生激素瘦素的表达并刺激其分泌。然而,ET -1对抵抗素分泌的影响尚未确定。为了明确ET -1对抵抗素分泌的影响,将3T3 -L1成纤维细胞分化为脂肪细胞,并使其成熟14天。细胞分别与ET -1(1 - 100 nM)、胰岛素(1 - 100 nM)、胰岛素 + ET -1(100 nM I + E)或相应的溶剂或拮抗剂孵育24小时。在孵育期结束时,通过免疫印迹和光密度分析测定培养基中抵抗素的分泌量。ET -1(1 - 100 nM)可使基础抵抗素分泌量显著降低,分别降低49%(1 nM)、43%(10 nM)和59%(100 nM)。胰岛素(1 - 100 nM)可使3T3 -L1脂肪细胞的抵抗素分泌呈浓度依赖性增加(1 nM时增加42%,10 nM时增加55%,100 nM时增加86%,与对照组相比)。ET -1(100 nM)几乎完全抑制了胰岛素刺激的抵抗素分泌(94%)。与ET(A)受体拮抗剂BQ - 610共同孵育可抑制ET -1对抵抗素蛋白分泌的影响。总之,我们的研究表明,ET -1可抑制胰岛素对抵抗素分泌的基础刺激和激素刺激。这些发现表明,在3T3 -L1脂肪细胞中,抵抗素的分泌与包括瘦素在内的其他脂肪组织因子的调节方式相似。此外,我们的研究结果表明,血管因子如ET -1可能通过脂肪细胞衍生的激素(包括瘦素和抵抗素)来调节全身能量代谢。